135 related articles for article (PubMed ID: 22475892)
1. Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer.
I HS; Kim SJ; Kim IJ; Kim K
Clin Nucl Med; 2012 May; 37(5):442-6. PubMed ID: 22475892
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of volumetric parameters measured by F-18 FDG PET/CT for lymph node status in patients with surgically resected rectal cancer.
Jo HJ; Kim SJ; Kim IJ; Kim S
Ann Nucl Med; 2014 Apr; 28(3):196-202. PubMed ID: 24532377
[TBL] [Abstract][Full Text] [Related]
3. Determination of regional lymph node status using (18)F-FDG PET/CT parameters in oesophageal cancer patients: comparison of SUV, volumetric parameters and intratumoral heterogeneity.
Kim SJ; Pak K; Chang S
Br J Radiol; 2016; 89(1058):20150673. PubMed ID: 26607643
[TBL] [Abstract][Full Text] [Related]
4. Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
Kim SJ; Kim YK; Kim IJ; Kim YD; Lee MK
Clin Nucl Med; 2011 Jun; 36(6):434-9. PubMed ID: 21552019
[TBL] [Abstract][Full Text] [Related]
5. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
Shum WY; Hsieh TC; Yeh JJ; Chen JH; Su CC; Liang JA; Kao CH
Eur J Radiol; 2012 May; 81(5):1024-8. PubMed ID: 21458941
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer.
Manabe O; Hattori N; Hirata K; Itoh K; Hosokawa M; Takahashi H; Oyama-Manabe N; Tamaki N
J Nucl Med; 2013 May; 54(5):670-6. PubMed ID: 23516310
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
[TBL] [Abstract][Full Text] [Related]
12. A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus.
Yu W; Fu XL; Zhang YJ; Xiang JQ; Shen L; Chang JY
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e759-65. PubMed ID: 21470788
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
Kim BH; Kim SJ; Kim H; Jeon YK; Kim SS; Kim IJ; Kim YK
Nucl Med Commun; 2013 Sep; 34(9):868-76. PubMed ID: 23797273
[TBL] [Abstract][Full Text] [Related]
14. Clinical Significance of FDG-PET to Predict Pathologic Tumor Invasion and Lymph Node Metastasis of Superficial Esophageal Squamous Cell Carcinoma.
Furukawa T; Hamai Y; Hihara J; Emi M; Yamakita I; Ibuki Y; Okada M
Ann Surg Oncol; 2016 Nov; 23(12):4086-4092. PubMed ID: 27352201
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional positron emission tomography image texture analysis of esophageal squamous cell carcinoma: relationship between tumor 18F-fluorodeoxyglucose uptake heterogeneity, maximum standardized uptake value, and tumor stage.
Dong X; Xing L; Wu P; Fu Z; Wan H; Li D; Yin Y; Sun X; Yu J
Nucl Med Commun; 2013 Jan; 34(1):40-6. PubMed ID: 23111378
[TBL] [Abstract][Full Text] [Related]
17. Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.
Shum WY; Ding HJ; Liang JA; Yen KY; Chen SW; Kao CH
Anticancer Res; 2012 Sep; 32(9):4163-8. PubMed ID: 22993379
[TBL] [Abstract][Full Text] [Related]
18. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
[TBL] [Abstract][Full Text] [Related]
19. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer.
Yuan S; Yu Y; Chao KS; Fu Z; Yin Y; Liu T; Chen S; Yang X; Yang G; Guo H; Yu J
J Nucl Med; 2006 Aug; 47(8):1255-9. PubMed ID: 16883002
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]